Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Martin Cannon

Concepts (301)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dendritic Cells
27
2025
133
4.400
 Why?
Ovarian Neoplasms
24
2025
458
4.220
 Why?
Cancer Vaccines
13
2020
78
2.820
 Why?
Immunotherapy
13
2025
240
2.630
 Why?
Th17 Cells
3
2020
26
1.410
 Why?
Antigens, Neoplasm
11
2019
146
1.260
 Why?
Myxoma virus
2
2025
15
1.130
 Why?
Oncolytic Virotherapy
2
2025
21
1.130
 Why?
CD4-Positive T-Lymphocytes
8
2023
163
1.010
 Why?
Oncolytic Viruses
1
2025
13
0.940
 Why?
Uterine Cervical Neoplasms
13
2011
299
0.900
 Why?
Oncogene Proteins, Viral
7
2011
54
0.760
 Why?
Neoplasm Recurrence, Local
3
2020
630
0.730
 Why?
T-Lymphocytes, Regulatory
6
2011
83
0.690
 Why?
T-Lymphocytes, Cytotoxic
12
2013
65
0.660
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
3
2014
14
0.620
 Why?
Lymphocytes, Tumor-Infiltrating
4
2019
78
0.570
 Why?
Neoplasms
4
2019
1288
0.540
 Why?
CD8-Positive T-Lymphocytes
11
2023
128
0.530
 Why?
Antibodies, Monoclonal
5
2019
475
0.530
 Why?
DNA-Binding Proteins
5
2007
424
0.520
 Why?
Interleukin-17
2
2020
33
0.510
 Why?
Adjuvants, Immunologic
4
2025
52
0.490
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
94
0.490
 Why?
Female
43
2025
28055
0.440
 Why?
T-Lymphocytes
5
2017
316
0.430
 Why?
Cell Line, Tumor
14
2025
1418
0.430
 Why?
Ascites
1
2014
32
0.420
 Why?
Immunologic Surveillance
2
2011
10
0.420
 Why?
Humans
54
2025
52114
0.380
 Why?
Cytokines
4
2014
621
0.380
 Why?
Signal Transduction
3
2017
1699
0.380
 Why?
Carcinoma
2
2017
136
0.380
 Why?
T-Lymphocytes, Helper-Inducer
2
2011
40
0.360
 Why?
Immunotherapy, Active
1
2011
4
0.360
 Why?
Serine Endopeptidases
3
2009
50
0.350
 Why?
Cytotoxicity, Immunologic
7
2011
56
0.350
 Why?
Animals
17
2025
13332
0.320
 Why?
Adoptive Transfer
1
2009
29
0.310
 Why?
Immunotherapy, Adoptive
3
2005
155
0.300
 Why?
Interferon-gamma
7
2020
172
0.290
 Why?
Epitopes, T-Lymphocyte
3
2008
25
0.280
 Why?
Mice
10
2025
5877
0.270
 Why?
Lymphocyte Activation
3
2005
160
0.260
 Why?
Papillomavirus Vaccines
1
2007
69
0.250
 Why?
Herpesvirus 4, Human
2
2005
44
0.250
 Why?
Immunodominant Epitopes
2
2008
9
0.250
 Why?
Dependovirus
3
2011
103
0.220
 Why?
Virus Replication
1
2025
150
0.210
 Why?
HLA-A2 Antigen
3
2009
11
0.210
 Why?
Cell Transformation, Viral
1
2003
25
0.200
 Why?
Cell Line, Transformed
1
2003
73
0.200
 Why?
Poxviridae Infections
1
2022
4
0.200
 Why?
Poxviridae
1
2022
7
0.190
 Why?
Interferon Type I
1
2022
28
0.190
 Why?
Cystadenocarcinoma, Serous
5
2009
73
0.190
 Why?
Vaccination
4
2010
296
0.180
 Why?
Disease-Free Survival
2
2020
462
0.180
 Why?
Papillomavirus E7 Proteins
5
2011
32
0.180
 Why?
Interleukin-10
2
2017
81
0.180
 Why?
Receptor, erbB-2
4
2008
79
0.180
 Why?
Genes, MHC Class I
3
2008
11
0.180
 Why?
Flow Cytometry
8
2013
397
0.180
 Why?
Membrane Proteins
4
2011
328
0.170
 Why?
Testis
2
2011
72
0.170
 Why?
Injections, Intradermal
1
2020
14
0.170
 Why?
Macrophages
4
2022
360
0.170
 Why?
Immunity, Humoral
1
2020
23
0.170
 Why?
Coculture Techniques
3
2014
142
0.170
 Why?
Folate Receptor 1
1
2020
27
0.160
 Why?
Cell Movement
2
2019
273
0.160
 Why?
Carcinoma, Hepatocellular
1
2022
199
0.160
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
234
0.160
 Why?
Carcinoma, Lewis Lung
1
2019
10
0.160
 Why?
B-Lymphocytes
5
2017
180
0.160
 Why?
Repressor Proteins
3
2011
150
0.160
 Why?
Melanoma, Experimental
1
2019
34
0.150
 Why?
Self Tolerance
1
2019
1
0.150
 Why?
Costimulatory and Inhibitory T-Cell Receptors
1
2019
1
0.150
 Why?
Liver Neoplasms
1
2022
332
0.150
 Why?
Transplantation, Autologous
1
2020
480
0.150
 Why?
Aged
12
2020
10142
0.150
 Why?
Cells, Cultured
6
2014
1568
0.140
 Why?
Cytotoxicity Tests, Immunologic
4
2005
26
0.140
 Why?
N-Acetylglucosaminyltransferases
1
2017
14
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2017
39
0.140
 Why?
Middle Aged
16
2020
13028
0.130
 Why?
Receptors, Notch
1
2017
28
0.130
 Why?
HLA Antigens
4
2006
53
0.130
 Why?
Human Umbilical Vein Endothelial Cells
2
2014
102
0.130
 Why?
Neoplastic Stem Cells
1
2017
90
0.130
 Why?
Carcinoma, Papillary
3
2005
50
0.120
 Why?
Genetic Vectors
3
2011
128
0.120
 Why?
Poliovirus Vaccine, Oral
2
2005
4
0.120
 Why?
Adult
15
2011
14095
0.120
 Why?
Poliovirus
2
2005
10
0.120
 Why?
Neoplasm Proteins
1
2017
328
0.110
 Why?
Clinical Trials, Phase I as Topic
1
2015
24
0.110
 Why?
Adenocarcinoma
3
2004
401
0.110
 Why?
Galectin 3
1
2014
14
0.110
 Why?
Antigen Presentation
5
2009
26
0.110
 Why?
Kallikreins
2
2005
19
0.110
 Why?
Neoplasm Invasiveness
3
2017
277
0.110
 Why?
Cystadenocarcinoma, Papillary
2
2005
14
0.110
 Why?
Histocompatibility Antigens Class I
2
2005
47
0.110
 Why?
Peptide Fragments
4
2009
207
0.100
 Why?
Endometrial Neoplasms
2
2005
143
0.100
 Why?
Uterine Neoplasms
2
2005
59
0.100
 Why?
Papillomavirus Infections
3
2011
171
0.100
 Why?
Mutation
1
2019
1318
0.100
 Why?
Mice, Inbred C57BL
3
2017
1872
0.100
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
136
0.100
 Why?
Lymphocytes
1
2013
146
0.090
 Why?
Antigens, Viral
3
2007
43
0.090
 Why?
Killer Cells, Natural
4
2005
112
0.090
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2011
4
0.090
 Why?
rho GTP-Binding Proteins
1
2011
8
0.090
 Why?
Clonal Anergy
1
2011
13
0.090
 Why?
A Kinase Anchor Proteins
1
2011
3
0.090
 Why?
Calmodulin-Binding Proteins
1
2011
10
0.090
 Why?
Antigen-Presenting Cells
1
2011
22
0.090
 Why?
Drug Resistance, Neoplasm
5
2017
324
0.090
 Why?
Antigens, Surface
1
2011
37
0.090
 Why?
Human papillomavirus 16
1
2011
44
0.090
 Why?
Antineoplastic Agents, Alkylating
1
2011
77
0.090
 Why?
Immunity, Cellular
2
2008
62
0.090
 Why?
Uterine Cervical Dysplasia
1
2011
51
0.090
 Why?
Cyclophosphamide
1
2011
173
0.080
 Why?
Prostate
1
2011
116
0.080
 Why?
Diphosphonates
1
2011
92
0.080
 Why?
Imidazoles
1
2011
123
0.080
 Why?
Gene Expression Regulation, Neoplastic
4
2011
853
0.080
 Why?
Phenotype
1
2013
794
0.080
 Why?
Papillomaviridae
3
2005
104
0.080
 Why?
Neoplasm Staging
3
2007
766
0.080
 Why?
Gene Expression Profiling
2
2005
1101
0.080
 Why?
K562 Cells
2
2008
41
0.080
 Why?
Carrier Proteins
1
2011
316
0.080
 Why?
Tumor Microenvironment
2
2023
246
0.080
 Why?
CA-125 Antigen
1
2008
16
0.070
 Why?
Immediate-Early Proteins
1
2008
18
0.070
 Why?
Cytomegalovirus
1
2008
30
0.070
 Why?
Green Fluorescent Proteins
1
2008
85
0.070
 Why?
RNA, Messenger
4
2005
1135
0.070
 Why?
Interleukin-4
2
2005
40
0.070
 Why?
Antibody Formation
1
2007
51
0.070
 Why?
Prostatic Neoplasms
1
2011
396
0.070
 Why?
Antibodies, Viral
1
2007
110
0.070
 Why?
Amino Acid Sequence
2
2005
566
0.070
 Why?
RNA Interference
2
2017
185
0.070
 Why?
Molecular Sequence Data
2
2005
766
0.060
 Why?
Ovary
3
2017
103
0.060
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
411
0.060
 Why?
Recombinant Proteins
1
2007
492
0.060
 Why?
Breast Neoplasms
3
2003
1199
0.060
 Why?
Hypersensitivity, Delayed
1
2005
18
0.060
 Why?
Monocytes
2
2022
126
0.060
 Why?
Neoplasms, Squamous Cell
1
2005
7
0.060
 Why?
Cell Line
4
2010
1018
0.060
 Why?
Electroporation
1
2005
18
0.060
 Why?
Poliomyelitis
1
2005
5
0.060
 Why?
Enterotoxins
1
2005
12
0.060
 Why?
Gene Transfer Techniques
1
2005
44
0.060
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
580
0.060
 Why?
Interleukin-12
1
2005
26
0.060
 Why?
Genes, erbB-2
1
2005
8
0.060
 Why?
Immunologic Memory
1
2005
32
0.060
 Why?
Antigens, Heterophile
1
2005
1
0.060
 Why?
Plasmodium falciparum
1
2005
23
0.060
 Why?
Burkitt Lymphoma
1
2005
27
0.060
 Why?
Endemic Diseases
1
2005
25
0.060
 Why?
Malaria, Falciparum
1
2005
21
0.060
 Why?
Epstein-Barr Virus Infections
1
2005
32
0.060
 Why?
Gangliosides
1
2004
4
0.060
 Why?
Ascitic Fluid
1
2004
13
0.050
 Why?
Proteins
2
2005
347
0.050
 Why?
Genetic Therapy
1
2005
124
0.050
 Why?
Ovariectomy
1
2004
113
0.050
 Why?
Vaccines, Subunit
1
2004
15
0.050
 Why?
Hysterectomy
1
2004
90
0.050
 Why?
Immunization, Passive
1
2004
28
0.050
 Why?
Clinical Trials as Topic
2
2007
463
0.050
 Why?
Interleukin-6
1
2005
274
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2019
392
0.050
 Why?
Cell Differentiation
2
2004
670
0.050
 Why?
Protein Binding
1
2005
665
0.050
 Why?
Epithelial Cells
1
2005
214
0.050
 Why?
Vesiculovirus
1
2022
6
0.050
 Why?
Virus Latency
1
2003
53
0.050
 Why?
Vaccinia virus
1
2022
6
0.050
 Why?
Host Specificity
1
2022
5
0.050
 Why?
Cell Adhesion Molecules
1
2003
88
0.050
 Why?
Cell Communication
1
2003
72
0.050
 Why?
Nucleotidyltransferases
1
2022
15
0.050
 Why?
Disease Models, Animal
2
2022
1467
0.050
 Why?
Mammals
1
2022
59
0.050
 Why?
Tumor Cells, Cultured
4
2003
445
0.050
 Why?
Xenograft Model Antitumor Assays
2
2017
216
0.050
 Why?
Down-Regulation
1
2003
343
0.050
 Why?
Rabbits
1
2022
371
0.050
 Why?
Disease Progression
2
2019
866
0.050
 Why?
Blood Transfusion
1
2002
129
0.050
 Why?
Radiotherapy
1
2002
128
0.050
 Why?
Viral Proteins
1
2022
164
0.040
 Why?
Immunohistochemistry
4
2005
975
0.040
 Why?
Carcinoma, Squamous Cell
1
2004
330
0.040
 Why?
Transcriptome
1
2022
363
0.040
 Why?
Endothelium
1
2019
38
0.040
 Why?
Intercellular Adhesion Molecule-1
1
2019
59
0.040
 Why?
Gene Expression
3
2008
618
0.040
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2004
1020
0.040
 Why?
Injections, Intraperitoneal
2
2010
56
0.030
 Why?
Tissue Banks
1
2017
9
0.030
 Why?
Mice, Inbred NOD
1
2017
90
0.030
 Why?
Antibodies, Monoclonal, Humanized
3
2004
232
0.030
 Why?
STAT3 Transcription Factor
1
2017
86
0.030
 Why?
Glycosylation
1
2017
103
0.030
 Why?
Tumor Burden
1
2017
133
0.030
 Why?
RNA, Small Interfering
1
2017
215
0.030
 Why?
Multiple Myeloma
1
2011
2999
0.030
 Why?
Protein Processing, Post-Translational
1
2017
151
0.030
 Why?
Kaplan-Meier Estimate
1
2017
482
0.030
 Why?
Lung Neoplasms
1
2002
624
0.030
 Why?
Survival Analysis
2
2010
667
0.030
 Why?
Apoptosis
2
2014
1117
0.030
 Why?
Perforin
2
2005
12
0.030
 Why?
Pore Forming Cytotoxic Proteins
2
2005
11
0.030
 Why?
Anti-Bacterial Agents
1
2019
796
0.030
 Why?
Neovascularization, Pathologic
1
2014
158
0.030
 Why?
Interleukin-2
2
2003
68
0.020
 Why?
Membrane Glycoproteins
2
2005
238
0.020
 Why?
Vaginal Smears
1
2011
28
0.020
 Why?
Organ Specificity
1
2011
116
0.020
 Why?
Prostate-Specific Antigen
1
2011
43
0.020
 Why?
DNA, Viral
1
2011
138
0.020
 Why?
Time Factors
2
2010
2970
0.020
 Why?
Major Histocompatibility Complex
1
2010
13
0.020
 Why?
Prognosis
2
2005
2093
0.020
 Why?
Transduction, Genetic
1
2008
44
0.020
 Why?
Fluorescent Antibody Technique
1
2008
109
0.020
 Why?
Leukocytes, Mononuclear
1
2008
122
0.020
 Why?
Alphapapillomavirus
1
2007
13
0.020
 Why?
T-Lymphocyte Subsets
1
2007
40
0.020
 Why?
Models, Immunological
1
2007
8
0.020
 Why?
Aged, 80 and over
2
2005
3382
0.020
 Why?
Immune Tolerance
1
2007
91
0.020
 Why?
Adolescent
2
2011
6681
0.020
 Why?
HLA-B Antigens
1
2006
8
0.020
 Why?
Clone Cells
1
2006
76
0.020
 Why?
Immunity, Innate
1
2007
112
0.020
 Why?
Male
3
2011
26652
0.020
 Why?
Combined Modality Therapy
1
2007
634
0.010
 Why?
Claudin-3
1
2005
5
0.010
 Why?
Claudin-4
1
2005
7
0.010
 Why?
Mice, Inbred C3H
1
2005
81
0.010
 Why?
Protein Sorting Signals
1
2005
7
0.010
 Why?
Peptides
1
2006
234
0.010
 Why?
Protein Engineering
1
2005
18
0.010
 Why?
Histocompatibility Antigens Class II
1
2005
34
0.010
 Why?
Mice, SCID
1
2005
178
0.010
 Why?
Plasmids
1
2005
164
0.010
 Why?
Species Specificity
1
2005
191
0.010
 Why?
Protein Folding
1
2005
60
0.010
 Why?
Epithelium
1
2004
64
0.010
 Why?
Endocytosis
1
2005
47
0.010
 Why?
Receptors, Cell Surface
1
2005
110
0.010
 Why?
Carboplatin
1
2004
56
0.010
 Why?
Radiotherapy, Adjuvant
1
2004
63
0.010
 Why?
Transfection
1
2005
366
0.010
 Why?
Polymerase Chain Reaction
1
2005
460
0.010
 Why?
Paclitaxel
1
2004
90
0.010
 Why?
Antineoplastic Agents, Hormonal
1
2004
53
0.010
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2003
12
0.010
 Why?
Tumor Stem Cell Assay
1
2003
16
0.010
 Why?
Proportional Hazards Models
1
2005
439
0.010
 Why?
Cervix Uteri
1
2004
49
0.010
 Why?
Up-Regulation
1
2005
459
0.010
 Why?
Swine
1
2005
426
0.010
 Why?
Kinetics
1
2005
616
0.010
 Why?
Keratinocytes
1
2004
93
0.010
 Why?
Receptors, Interleukin-2
1
2002
6
0.010
 Why?
Lymphocyte Subsets
1
2002
14
0.010
 Why?
Receptors, Antigen, T-Cell
1
2003
46
0.010
 Why?
Cell Culture Techniques
1
2003
97
0.010
 Why?
Leukocytes
1
2003
59
0.010
 Why?
Antigens, CD19
1
2002
28
0.010
 Why?
Cell Death
1
2003
169
0.010
 Why?
Receptors, IgG
1
2002
24
0.010
 Why?
Doxorubicin
1
2004
242
0.010
 Why?
Cisplatin
1
2004
284
0.010
 Why?
Immunophenotyping
1
2002
117
0.010
 Why?
Survival Rate
1
2005
945
0.010
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2002
47
0.010
 Why?
Tumor Virus Infections
1
2002
48
0.010
 Why?
Fatal Outcome
1
2002
192
0.010
 Why?
Young Adult
1
2011
4307
0.010
 Why?
Cell Division
1
2002
288
0.010
 Why?
Case-Control Studies
1
2004
1193
0.010
 Why?
Prospective Studies
1
2004
2424
0.010
 Why?
Risk Factors
1
2004
3922
0.010
 Why?
Antineoplastic Agents
1
2002
1214
0.010
 Why?
Cannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (301) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department